SavedAdd your journal

Journals / Harran Üniversitesi Tıp Fakültesi Dergisi / 2017 / Cilt: 14 - Sayı: 3(suppl. 1)

An Immunohistochemical Investigation of VGSCs in Prostate Cancer Patients in Sanliurfa

Şanlıurfa'daki Prostat Kanseri Hastalarında VGSC'lerin İmmünohistokimyasal Olarak İncelenmesi

Ulaş ALABALIK
Cemal CAVUS
Hatice GUMUSHAN AKTAS
Pages
23–30
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was studied with rat cerebellum tissue as positive control in accordance with immunohistochemical the

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: In this study, it was aimed to investigate presence of the protein which encoded by Nav1.7 gene in prostate tissue specimens obtained from some patients consulted to Harran University Medical Faculty Hospital and Mehmet Akif Inan Training and Research Hospital in Sanliurfa owing to genitourinary system disorders.
📊
Key Findings & Data:Materials and Methods: In this study, it was used the prostate tissue samples which belong to 20 diagnosed patients (benign prostatic hyperplasia, prostatic intraepithelial neoplasia, non-metastatic prostate cancer and metastatic prostate cancer), and four normal prostate.
💡
Conclusion & Impact:It was studied with rat cerebellum tissue as positive control in accordance with immunohistochemical the
🔬Design:Research Article
📍Scope:2012-2014 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: In this study, it was aimed to investigate presence of the protein which encoded by Nav1.7 gene in prostate tissue specimens obtained from some patients consulted to Harran University Medical Faculty Hospital and Mehmet Akif Inan Training and Research Hospital in Sanliurfa owing to genitourinary system disorders. Materials and Methods: In this study, it was used the prostate tissue samples which belong to 20 diagnosed patients (benign prostatic hyperplasia, prostatic intraepithelial neoplasia, non-metastatic prostate cancer and metastatic prostate cancer), and four normal prostate. These specimens obtained from Pathology Department archives of Harran University Faculty of Medicine Hospital and Mehmet Akif Inan Training and Research Hospital belong to 2012-2014. For labelling, Anti-Sodium channel Nav1.7 monoclonal antibody (Millipore, Merck, USA) was used. It was studied with rat cerebellum tissue as positive control in accordance with immunohistochemical the

Özet

Amaç: rahatsızlıkları nedeniyle Şanlıurfa'daki Harran Üniversitesi Tıp Fakültesi Hastanesi ve Mehmet Akif İnan Eğitim ve Araştırma Hastanesi'ne başvuran bazı hastalardan alınmış prostat doku örneklerinde Nav1.7 geni tarafından kodlanan proteinin varlığının araştırılması amaçlanmıştır. Materyal ve Metod: Çalışmada, tanı konulmuş (benign prostatik hiperplazi, prostatik intraepitelyal neoplazi, metastatik olmayan prostat kanseri ve metastatik prostat kanseri) 20 hastaya ait prostat dokusu örnekleri ve dört normal prostat kullanıldı. Harran Üniversitesi Tıp Fakültesi Hastanesi ile Mehmet Akif İnan Eğitim ve Araştırma Hastanesi'nin Patoloji arşivlerinden alınan bu numuneler 2012-2014 yıllarına aittir. İşaretleme için anti-sodyum kanalı Nav1.7 monoklonal antikor (Millipore, Merck, ABD) kullanıldı. Pozitif kontrol olarak, üretici firmanın önerisine göre, sıçan beyincik dokusu ile çalışıldı. İmmunohistokimyasal boyama işlemi otomatik immünhistokimya cihazında (Ventana, Roche, ABD) yapıldı.

🔖

Cite This Article

ALABALIK, U., CAVUS, C., AKTAS, H. G. (2022). An Immunohistochemical Investigation of VGSCs in Prostate Cancer Patients in Sanliurfa. Harran Üniversitesi Tıp Fakültesi Dergisi, Cilt: 14 - Sayı: 3(suppl. 1), 23–30. https://ajindex.com/articles/534101

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Stewart BW. and Wild CP. World Cancer Report 2014. Lyon: World Health Organization; IARC Nonserial Publication, 2014: 632 s. Siegel RL., Miller KD., Jemal A. Cancer statistics, 2017. CA Cancer J Clin 2017; 67:7-30. Şencan İ.ve Keskinkılıç B. Türkiye Kanser İstatistikleri, T.C. Sağlık Bakanlığı, Türkiye Halk Sağlığı Kurumu, Ankara, 2017: 48 s. Staunton L., Tonry C., Lis R., Espina V., Liotta L., Inziatari R., Bowden M., Fabre A., Oleary J., Finn SP., Loda M. and Pennington SR. Pathology-driven comprehensive proteomic profiling of the prostate cancer tumour microenvironment. Mol Cancer Res 2016; 15(3): 1-13. Anonymus, 2017. Prostate Cancer Rates by Race Ethnicity and https://www.cdc.gov/cancer/prostate/statistics/race.htm, [Ziyaret tarihi: 27/10/2017]. Centers for Disease Control and Prevention. [online], Shelley M., Wilt TJ., Coles B., Mason MD. for localised Cochrane Db Syst Rev 2007; 18(3): CD005010. Woodhouse EC., Chuaqui RF., Liotta L. General mechanisms of metastasis. Cancer Supplement 1997; 80(8): 1529-37.Fraser SP., Salvador V., Manning EA., Mizal J., Altun S., Raza M., Berridge RJ., Djamgoz MBA. Contribution of functional voltage-gated Na+ channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer: I. Lateral motility. J Cell Physiol 2003; 195: 479-87.
  2. Lang F., Föller, M., Lang, KS., Lang, PA., Ritter, M., Gulbins, E., Vereninov, A., Huber, SM. Ion channels in cell proliferation and apoptotic cell death. J Membrane Biol 2005; 205: 147-57. Ashcroft FM. From molecule to malady. Nature 2006; 440 (23): 440-7. Conti M. Targetting ion channels for new strategies in cancer diagnosis and therapy. Curr Clin Pharmacol 2007; 2: 135-44.
  3. Grimes JA., Fraser SP., Stephens GJ., Downing JEG., Laniado, ME., Foster CS., Abel PD., Djamgoz MBA. Differential expression of voltage- activated Na+ currents in two prostatic tumour cell lines: contribution to invasiveness in vitro. FEBS Lett 1995; 369: 290-4.
  4. Grimes JA., Djamgoz MBA. Electrophysiological characterization of voltage- gated Na+ current expressed in the highly metastatic Mat-LyLu cell line of rat prostate cancer. J Cell Physiol 1998; 175: 50-8.
  5. Diss, JKJ., Stewart, D., Pani F., Foster CS., Walker MM., Patel A., Djamgoz MBA. A potential novel marker for human prostate cancer: voltage- gated sodium channel expression in vitro. Prostate Cancer P D 2005; 8: 266-73.
  6. Fraser SP., Diss, JKJ., Chioni, AM., Mycielska ME., Pan H., Yamaci RF., Pani F., Siwy Z., Krasowska M., Grzywna Z.,